MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AMPH — Amphastar Pharmaceuticals, Inc.
NasdaqAmphastar Pharmaceuticals, Inc.
$25.43
+0.08(+0.32%)
- O
- 25.46
- H
- 25.55
- L
- 25.06
- V
- 372.33K
⏱️ End-of-day dataAs of Oct 2, 2026
AMPH — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $17.09M | $17.02M | $21.63M | $18.77M | N/A | N/A |
| Other Short Term Investments | $12.10M | $11.26M | $59.94M | $44.06M | N/A | N/A |
| Accounts Receivable | $14.78M | $14.36M | $14.68M | $13.30M | N/A | N/A |
| Inventory | $17.02M | $17.69M | $18.59M | $19.17M | N/A | N/A |
| Restricted Cash | $2.44M | $2.44M | $2.44M | $2.44M | N/A | N/A |
| Other Current Assets | $11.65M | $13.15M | $26.02M | $20.33M | N/A | N/A |
| Total Current Assets | $63.37M | $63.60M | $63.95M | $58.08M | N/A | N/A |
| Properties | $71.68M | $43.15M | $44.84M | $44.49M | N/A | N/A |
| Land And Improvements | $7.53M | $7.55M | $7.55M | $7.55M | N/A | N/A |
| Machinery Furniture Equipment | $34.29M | $34.21M | $33.56M | $33.28M | N/A | N/A |
| Construction In Progress | $27.73M | $24.41M | $24.04M | $40.65M | N/A | N/A |
| Leases | $46.14M | $46.10M | $46.04M | $46.04M | N/A | N/A |
| Accumulated Depreciation | $-31.34M | $-30.63M | $-29.83M | $-29.05M | N/A | N/A |
| Goodwill | $56.30M | $56.94M | $57.56M | $58.19M | N/A | N/A |
| Intangible Assets | $55.63M | $56.26M | $56.88M | $57.51M | N/A | N/A |
| Other Non Current Assets | $75.94M | $73.60M | $10.10M | $99.22M | N/A | N/A |
| Total Non Current Assets | $101.45M | $99.33M | $102.68M | $103.45M | N/A | N/A |
| Total Assets | $164.82M | $162.93M | $166.62M | $161.53M | N/A | N/A |
| Accounts Payable | $35.50M | $32.59M | $40.54M | $41.88M | N/A | N/A |
| Accrued Expenses | $11.72M | $11.58M | $15.03M | $12.47M | N/A | N/A |
| Short Term Debt | $11.38M | $9.57M | $8.75M | $8.81M | N/A | N/A |
| Tax Payable | 414,000.00 | 239,000.00 | $5.63M | $1.05M | N/A | N/A |
| Total Current Liabilities | $16.45M | $15.82M | $20.52M | $17.64M | N/A | N/A |
| Long Term Debt | $67.50M | $64.64M | $64.80M | $64.67M | N/A | N/A |
| Deferred Liabilities | $5.93M | $5.93M | $6.96M | $6.96M | N/A | N/A |
| Other Non Current Liabilities | $29.36M | $29.98M | $29.27M | $27.80M | N/A | N/A |
| Total Non Current Liabilities | $71.03M | $68.23M | $68.42M | $68.14M | N/A | N/A |
| Total Liabilities | $87.48M | $84.05M | $88.95M | $85.79M | N/A | N/A |
| Common Stock | 6,000.00 | 6,000.00 | 6,000.00 | 6,000.00 | N/A | N/A |
| Retained Earnings | $67.33M | $66.69M | $64.25M | $62.51M | $59.41M | $56.88M |
| Other Shareholders Equity | $-5.74M | $-5.31M | $-5.27M | $-5.36M | N/A | N/A |
| Total Shareholders Equity | $77.34M | $78.88M | $77.67M | $75.75M | N/A | N/A |
| Additional Paid In Capital | $54.38M | $53.54M | $52.72M | $52.06M | N/A | N/A |
| Treasury Stock | $43.80M | $40.81M | $38.77M | $38.28M | N/A | N/A |
| Investments And Advances | N/A | 0.00 | 0.00 | $2.05M | N/A | N/A |